Emerging Trends and Future Outlook of GLP-1 Receptor Agonists: The Role of Ozempic and Semaglutide in 2025
Photo By: , Source, CC Glucagon-like peptide-1 (GLP-1) receptor agonists have revolutionized the management of type 2 diabetes and obesity. As we approach 2025, the landscape of these therapeutic agents…
Read More »